Software developed by a University of Dayton Research Institute scientist to quickly diagnose COVID-19 has been exclusively licensed by Greenville, South Carolina, software development company Blue Eye Soft. The technology, which detected the presence of the COVID-19 disease on a dataset of chest X-rays in seconds with 98 percent accuracy, was adapted from existing medical diagnostic software in a matter of hours, then licensed in less than three days.
Blue Eye Soft owner Srikanth Kodeboyina — an alumnus of UD — and his team further developed the technology, and he plans to submit a full proposal to the FDA for approval within a matter of days. The company has already filed a provisional patent on the software.
Click here to read the complete story.
Story excerpt provided by University of Dayton News.
Originally published April 6, 2020.